Ritu Shah
Directeur Général chez ClostraBio, Inc.
Postes actifs de Ritu Shah
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
ClostraBio, Inc.
 ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Directeur Général | 24/01/2023 | - |
Portal Innovations LLC
 Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 01/12/2022 | - |
Historique de carrière de Ritu Shah
Anciens postes connus de Ritu Shah
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Corporate Officer/Principal | 01/07/2018 | 01/03/2021 |
| AVEXIS INC | Corporate Officer/Principal | 01/10/2017 | 01/07/2018 |
| PYXIS ONCOLOGY, INC. | Directeur des opérations | 01/03/2021 | - |
Formation de Ritu Shah
| University of Notre Dame | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PYXIS ONCOLOGY, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Health Technology |
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Health Technology |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Finance |
